Henning Gronbaek
Overview
Explore the profile of Henning Gronbaek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
309
Citations
6312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gantzel R, Moller E, Aagaard N, Watson H, Jepsen P, Gronbaek H
Hepatol Commun
. 2024 Jun;
8(7).
PMID: 38934679
Background: Sodium and water retention is a mainstay of the pathophysiology leading to ascites formation in patients with advanced cirrhosis. Refractory ascites denotes the most severe ascites status with limited...
12.
Risikesan J, Heeboll S, Kumarathas I, Sondergaard E, Johansen R, Ringgaard S, et al.
J Lipid Res
. 2024 Jun;
65(7):100580.
PMID: 38901559
This study aimed to determine whether obese men with nonalcoholic fatty liver disease (NAFLD) display differences between those with simple steatosis versus steatohepatitis (NASH) in splanchnic and hepatic FFA and...
13.
Zhang H, Targher G, Byrne C, Kim S, Wong V, Valenti L, et al.
Hepatol Int
. 2024 Jun;
18(4):1178-1201.
PMID: 38878111
Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, it...
14.
Hansen C, Lindvig K, Gronbaek H, Gluud L, Thiele M, Krag A
Ugeskr Laeger
. 2024 May;
186(19).
PMID: 38808766
This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease...
15.
Kornerup L, Andreassen M, Knigge U, Arveschoug A, Poulsen P, Kjaer A, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611027
Introduction: Pheochromocytomas and paragangliomas are rare neuroendocrine tumours that originate from chromaffin cells within the adrenal medulla or extra-adrenal sympathetic ganglia. Management of disseminated or metastatic pheochromocytomas and paragangliomas continues...
16.
Bager P, Bossen L, Gantzel R, Gronbaek H
PLoS One
. 2024 Mar;
19(3):e0301354.
PMID: 38551983
Background & Aims: Fatigue has high negative impact on many patients with primary biliary cholangitis (PBC) and treatment options are limited. Recently we showed favorable effects of four weeks of...
17.
Schurrle S, Eberlein U, Ansquer C, Beauregard J, Durand-Gasselin L, Gronbaek H, et al.
Eur J Nucl Med Mol Imaging
. 2024 Mar;
51(8):2428-2441.
PMID: 38528164
Purpose: To evaluate the dosimetry and pharmacokinetics of the novel radiolabelled somatostatin receptor antagonist [Lu]Lu-satoreotide tetraxetan in patients with advanced neuroendocrine tumours (NETs). Methods: This study was part of a...
18.
Gantzel R, Bagge C, Villadsen G, Rex K, Gronbaek H, Pedersen M
Int J Circumpolar Health
. 2024 Mar;
83(1):2327693.
PMID: 38465864
Autoimmune liver diseases are rare serious diseases causing chronic inflammation and fibrosis in the liver parenchyma and bile ducts. Yet, the prevalence and burden of autoimmune liver diseases are largely...
19.
Lonardo A, Bril F, Caldwell S, Eslam M, Fan J, Gish R, et al.
J Hepatol
. 2024 Feb;
80(5):e192-e194.
PMID: 38336589
No abstract available.
20.
Hagstrom H, Adams L, Allen A, Byrne C, Chang Y, Duseja A, et al.
Hepatol Commun
. 2024 Feb;
8(2).
PMID: 38315102
Background: Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research...